TP53 and cancer: For example, replacing the phenolic hydroxyl (-OH) group to a methyl (-CH3) of niclosamide is thought to abolish its mitochondrial uncoupling activity, resulting in a loss of anti-growth effect in both wild-type or p53-null cancer cells, suggesting that the antitumor effect of niclosamide relies on its uncoupling function (20).